英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
unforeseeable查看 unforeseeable 在百度字典中的解释百度英翻中〔查看〕
unforeseeable查看 unforeseeable 在Google字典中的解释Google英翻中〔查看〕
unforeseeable查看 unforeseeable 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Skin Cancer - The ASCO Post
    Exposure to Agent Orange in U S veterans was associated with an increased odds of developing acral melanoma compared with controls with and without cutaneous melanoma, according to findings published in JAMA Dermatology
  • 5-year overall survival after adjuvant treatment for stage III melanoma . . .
    Background: Adjuvant treatments for stage III cutaneous melanoma were approved based on significant improvement in recurrence free survival (RFS) with both anti-PD-1 and BRAF+MEK inhibitors However, registration trials have not demonstrated a significant overall survival (OS) benefit to date
  • Melanoma Trials You May Have Missed at ASCO 2026
    The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting brought meaningful advances across melanoma subtypes and Merkel cell carcinoma, a rare and aggressive skin cancer that continues to generate practice-informing data
  • Melanoma - ASCO Daily News
    Dr Pauline Funchain and Dr Allison Betof discuss practice-changing and paradigm-shifting abstracts in melanoma, Merkel cell carcinoma, and cellular therapies that were presented at the 2026 ASCO Annual Meeting
  • Experts Weigh In on Some of the Most Impactful Data in Melanoma From . . .
    Experts unpack key melanoma data shared during the 2026 ASCO Annual Meeting During the 2026 American Society of Clinical Oncoloy Annual Meeting, OncLive ® connected with experts to
  • Guidelines - ASCO
    ASCO Guidelines provide evidence-based recommendations and outline appropriate methods of treatment and care for clinicians The guidelines address specific clinical situations (disease-oriented) or the use of approved medical products, procedures, or tests (modality-oriented)
  • Skin cancer at ASCO 2026: Five late-breaking studies
    The late-breaking melanoma and skin cancer abstracts presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting offered new insights into treatment strategies for skin cancers which are often considered difficult-to-treat, including Merkel cell carcinoma and advanced melanoma
  • Abstracts Posters - ASCO
    A downloadable version of the 2026 ASCO Annual Meeting Proceedings is now available Users can view the full proceedings, or download individual tracks using the links below
  • Melanoma: Cutaneous, Version 2. 2026, NCCN Clinical Practice Guidelines . . .
    The NCCN Guidelines for Melanoma: Cutaneous provide strategies for the diagnosis, treatment, and follow-up of patients with cutaneous melanoma, which is among the most common cancers in the United States The outcome of cutaneous melanoma is significantly influenced by stage at initial presentation
  • Stage II Melanoma: Adjuvant Pembrolizumab and Risk of New Skin Cancers
    This post hoc analysis evaluated the incidence and time to diagnosis of new invasive primary melanoma, new melanoma in situ, basal cell carcinoma, and cutaneous squamous cell carcinoma





中文字典-英文字典  2005-2009